
Influenza A Non-structural protein 1 2315-2323, FLYNLLTRV
Description
About Influenza A Non-structural protein 1 2315-2323, FLYNLLTRV
The Influenza A Non-structural protein 1 Peptide (IEDB: 606710) is a high quality epitope peptide for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxicity or proliferation assays. The Non-structural protein Peptide, H-FLYNLLTRV-OH (Uniprot: Genbank: WTM49646.1 aa: 2315-2323) from JPT is produced under strict quality control and quality management.
Influenza A Non-structural protein 1 2315-2323, FLYNLLTRV - Specifications
- Peptide sequence: H-FLYNLLTRV-OH
- Amount: 1 mg
- Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS)
- Counterion: TFA
- Delivery Format: Freeze-dried in glass vial
- Application(s): T-cell Immunity
- Condition(s)/Topic(s): Melanoma
- Standard Delivery Time: approx. 3 weeks
JPT’s Antigen Peptides
Find your antigen peptide and select the connected PepMix™ Peptide Pool for efficient immune monitoring, mapping of T cell epitopes or development of immunotherapy and vaccines. JPT Peptide Technologies has substantial, long-standing expertise in providing peptides, peptidomimetics, and proteins to the global scientific community. Our highly skilled and committed scientific staff ensures that the most appropriate methods and techniques are selected for every synthesis project. All our catalog peptides are provided with HPLC-MS analyses to confirm the identity and demonstrate the high quality of our peptides.
Not found what you are looking for? Take a look at our Custom Peptide Synthesis!
Benefits of JPT’s Antigen Peptides
- All peptides are made in Germany
- Bulk orders or custom peptide snythesis upon request
- Synthesis protocols designed to avoid toxic contaminants and side products
- Provision of freeze dried aliquots for enhanced stability
- Proven track record for applications in clinical studies
- Order the connected PepMix™ Peptide Pool with your peptide!
References
References for Influenza A Non-structural protein 1 2315-2323, FLYNLLTRV
References:
Read References with JPT’s Antigen Peptides
Influenza A Non-structural protein 1 2315-2323, FLYNLLTRV has been described in:
Cancer immunotherapy. A dendritic cell vaccine increases the breadth and diversity of melanoma neoantigen-specific T cells., Science, 2015 (PMID: 25837513)
High-throughput determination of the antigen specificities of T cell receptors in single cells., Nat Biotechnol, 2018 (PMID: 30418433)
Documentation
Documentation for Influenza A Non-structural protein 1 2315-2323, FLYNLLTRV
Properties
Properties of Influenza A Non-structural protein 1 2315-2323, FLYNLLTRV
Properties | Values |
---|---|
Application: | T-cell immunity |
Category: | Antigen Peptides |
Condition / Topic: | Melanoma |
Layout: | Freeze-dried in glass vial |
Organism: | Influenza A |
Protein Name: | Non-structural protein |
Purity: | Trial Grade: each peptide purified to > 90% (HPLC/MS) |
Quantification: | No, Yes |
Further Information to Influenza A Non-structural protein 1 2315-2323, FLYNLLTRV
Information | Values |
---|---|
Sequence: | H-FLYNLLTRV-OH |
Specifications: | 9mer peptide as TFA salt |